Convatec Group Plc

(OTCGREY:CNVVF)

Latest On Convatec Group Plc (CNVVF):

Date/Time Type Description Signal Details
2024-04-25 06:03 ESTDividendA dividend of $0.04 has been announced on Mar 6, 2024. It will be paid May 23, 2024 with an ex-dividend date of Apr 25, 2024.Neutral
2023-08-17 06:03 ESTDividendA dividend of $0.01 has been announced on Aug 2, 2023. It will be paid Sep 28, 2023 with an ex-dividend date of Aug 17, 2023.Neutral
2022-08-25 06:03 ESTDividendA dividend of $0.01 has been announced on Aug 4, 2022. It will be paid Oct 6, 2022 with an ex-dividend date of Aug 25, 2022.Neutral
2022-08-06 19:10 ESTNewsConvaTec Group Plc (CNVVF) CEO Karim Bitar on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 21:10 ESTNewsConvaTec Group Plc GAAP EPS of $2.40, revenue of $1.05B beats by $30MN/A
2022-03-31 06:05 ESTDividendA dividend of $0.03 has been announced on Mar 8, 2022. It will be paid May 19, 2022 with an ex-dividend date of Mar 31, 2022.Neutral
2022-03-09 00:23 ESTNewsConvaTec Group Plc Non-GAAP EPS of $0.06, revenue of $2.03BN/A
2022-03-09 00:23 ESTNewsConvaTec Group Plc (CNVVF) CEO Karim Bitar on Q4 2021 Results - Earnings Call TranscriptN/A
2021-09-02 06:07 ESTDividendA dividend of $0.01 has been announced on Jul 30, 2021. It will be paid Oct 14, 2021 with an ex-dividend date of Sep 2, 2021.Neutral
2021-03-07 00:44 ESTNewsConvatec Group Plc (CNVVF) CEO Karim Bitar on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-06 13:30 ESTFinancialsCompany financials have been released.Neutral
2021-03-05 11:19 ESTNewsConvatec Group Plc revenue in-lineN/A
2021-03-05 11:19 ESTNewsConvatec Group Plc 2020 Q4 - Results - Earnings Call PresentationN/A
2020-11-26 23:24 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 02:23 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 18:44 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 15:35 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 07:54 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 11:39 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 05:33 ESTNewsConvaTec Group PLC (CNVVF) CEO Karim Bitar on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-08 10:46 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 08:32 ESTNewsConvatec Group Plc 2020 Q2 - Results - Earnings Call PresentationN/A
2020-08-06 15:17 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 06:01 ESTNewsConvatec Group Plc reports 1H resultsN/A
2020-07-30 19:25 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 07:24 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 23:38 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 17:23 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 15:16 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 20:04 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 11:28 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 19:09 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 02:58 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 15:02 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 07:11 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 08:44 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 07:49 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 03:29 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 08:07 ESTFinancialsCompany financials have been released.Neutral
2020-05-03 01:21 ESTNewsConvatec Group's (CNVVF) CEO Karim Bitar on Q1 2020 Results - Earnings Call TranscriptN/A
2020-05-02 22:40 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 18:58 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 11:44 ESTNewsConvatec Group reports Q1 revenuesN/A
2020-04-20 06:46 ESTFinancialsCompany financials have been released.Neutral
2020-04-14 17:12 ESTNewsConvatec Group Plc reports FY resultsN/A
2020-04-09 22:53 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 23:22 ESTFinancialsCompany financials have been released.Neutral
2020-04-02 06:09 ESTDividendA dividend of $0.03 has been announced on Feb 28, 2020. It will be paid May 14, 2020 with an ex-dividend date of Apr 2, 2020.Neutral
2020-04-02 06:09 ESTDividendA dividend of $0 has been announced on Feb 28, 2020. It will be paid May 14, 2020 with an ex-dividend date of Apr 2, 2020.Neutral
2020-03-25 22:51 ESTFinancialsCompany financials have been released.Neutral

About Convatec Group Plc (CNVVF):

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group Plc was incorporated in 2016 and is headquartered in Reading, the United Kingdom.

See Advanced Chart

General

  • Name Convatec Group Plc
  • Symbol CNVVF
  • Type Common Stock
  • Exchange OTCGREY
  • Currency USD
  • Country USA
  • Full Time Employees 9,600
  • Fiscal Year EndDecember
  • Web URLhttp://www.convatecgroup.com
View More

Valuation

  • Trailing PE 47.58
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin 6%
  • Operating Margin 12%
  • Return on Assets 4%
  • Return on Equity 7%
  • Revenue 1.89 billion
  • Earnings Per Share $0.06
  • Revenue Per Share $0.95
  • Gross Profit 1.02 billion
  • Quarterly Earnings Growth 5.1%
View More

Highlights

  • Market Capitalization 5.4 billion
  • EBITDA 390.8 million
  • Book Value Per Share $0.84
View More

Share Statistics

  • Shares Outstanding 1.95 billion
  • Shares Float 1.57 billion
  • % Held by Insiders 2028%
  • % Held by Institutions 63.74%
View More

Technicals

  • Beta 0.73
  • 52 Week High $2.78
  • 52 Week Low $2.36
  • 50 Day Moving Average 2.74
  • 200 Day Moving Average 2.57
View More

Dividends

  • Dividend Date 2017-10-20
  • ExDividend Date N/A
  • Dividend Per Share $0.06
  • Dividend Yield 0%
View More

Convatec Group Plc (CNVVF) Dividend Calendar:

CNVVF's last dividend payment was made to shareholders on October 20, 2017.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Convatec Group Plc (CNVVF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-12-31$N/A$0.01$0.00
2020-06-302020-09-30$N/A$0.01$0.00
2020-03-312020-06-30$N/A$0.01$0.00
2019-12-312020-03-31$469.15 million$0.01$0.00
2019-09-302019-12-31$469.15 million-$0.01$0.00
2019-06-302019-09-30$444.45 million-$0.01$0.00
2019-03-312019-06-30$444.45 million$0.01$0.00
2018-12-312019-03-31$455.4 million$0.01$0.00
2018-09-302018-12-31$455.4 million$0.03$0.00
2018-06-302018-09-30$536.14 million$0.03$0.00
2018-03-312018-06-30$566.67 million$0.03$0.00
2017-12-312018-03-31$466.65 million$0.03$0.00
2017-09-302017-12-31$466.65 million$0.03$0.00
2017-06-302017-09-30$415.65 million$0.03$0.00
2017-03-312017-06-30$415.65 million$0.01$0.00
2016-12-312017-03-31$429.7 million$0.01$0.00
2016-09-302016-12-31$429.7 million-$0.04$0.00
2016-06-302016-09-30-$0.04$0.00
2016-03-312016-06-30-$0.32$0.00
2015-12-312016-03-31-$0.36$0.00
2015-09-302015-12-31$0.81$0.00
2015-06-302015-09-30-$0.30$0.00
2015-03-312015-06-30-$0.69$0.00
2014-12-312015-03-31-$0.66$0.00
2014-09-302014-12-31-$1.25$0.00
2014-06-302014-09-30-$0.21$0.00
2014-03-312014-06-30-$0.47$0.00
2013-12-312014-03-31-$0.63$0.00
2013-09-302013-12-31-$0.58$0.00
2013-06-302013-09-30-$0.22$0.00
2013-03-312013-06-30-$0.33$0.00
2012-12-312013-03-31-$0.43$0.00
2012-09-302012-12-31$0.14$0.00
2012-06-302012-09-30-$0.45$0.00
2012-03-312012-06-30-$0.43$0.00
2011-12-312012-03-31-$0.69$0.00
2011-09-302011-12-31-$0.50$0.00
2011-06-302011-09-30$0.25$0.00
2011-03-312011-06-30-$1.19$0.00
2010-12-312011-03-31-$1.10$0.00
2010-09-302010-12-31-$2.70$0.00

Convatec Group Plc (CNVVF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A N/A 15.05 million
Income Before Tax N/A N/A N/A N/A -21.2 million
Selling General Administrative N/A N/A N/A N/A 185.6 million
Gross Profit N/A N/A N/A N/A 248.2 million
Ebit N/A N/A N/A N/A -5.2 million
Operating Income N/A N/A N/A N/A -5.2 million
Income Tax Expense 19.9 million 19.9 million 11.2 million 11.2 million -3.85 million
Total Revenue N/A N/A N/A N/A 469.15 million
Cost of Revenue N/A N/A N/A N/A 220.95 million
Total Other Income Expense Net N/A N/A N/A N/A -16 million
Net Income From Continuing Operations N/A N/A N/A N/A -17.35 million
Net Income Applicable to Common Shares 26.7 million 26.7 million 29.55 million 29.55 million -17.35 million
Cash Flow:
Date Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019
Investments N/A N/A N/A N/A N/A
Change to Liabilities 200000 200000 21.15 million 21.15 million 750000
Total Cash Flow from Investing Activities -18.35 million -18.35 million -20.85 million -20.85 million -15.55 million
Net Borrowings -5.15 million -5.15 million -58.6 million -58.6 million -20.7 million
Total Cash Flow from Financial Activities N/A N/A -76 million -76 million -50.25 million
Change to Operating Activities -150000 -150000 -20.7 million -20.7 million 21.35 million
Change in Cash N/A N/A 4.9 million 4.9 million 30.2 million
Total Cash from Operating Activities 77.55 million 77.55 million 103.9 million 103.9 million 97 million
Depreciation N/A N/A 55.45 million 55.45 million 49.45 million
Other Cash Flow from Investing Activities N/A N/A 200000 200000 200000
Change to Inventory N/A N/A 4.7 million 4.7 million 5.5 million
Change to Account Receivables N/A N/A 2.35 million 2.35 million -9.3 million
Other Cash Flow from Financing Activities N/A N/A -10.4 million -10.4 million N/A
Change to Net Income 9.95 million 9.95 million 61.85 million 61.85 million 3.45 million
Capital Expenditures N/A N/A 15.25 million 15.25 million 15.45 million
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A N/A N/A 2.05 billion
Total Stockholder Equity N/A N/A N/A N/A 1.56 billion
Other Current Liabilities 72.7 million 72.7 million N/A N/A 48.8 million
Total Assets N/A N/A N/A N/A 3.61 billion
Common Stock 245.5 million 245.5 million 245 million 245 million 242.9 million
Other Current Assets 6.4 million 6.4 million N/A N/A N/A
Retained Earnings -845.3 million -845.3 million -864.4 million -864.4 million -847.7 million
Other Liabilities 132.8 million 132.8 million 145.9 million 145.9 million 136.1 million
Other Assets 60.4 million 60.4 million 72.9 million 72.9 million 68.5 million
Cash N/A N/A N/A N/A 385.8 million
Total Current Liabilities 513.2 million 513.2 million N/A N/A 397.3 million
Other Stockholder Equity 2.16 billion 2.16 billion 2.05 billion 2.05 billion 2.11 billion
Property, Plant & Equipment 438 million 438 million 402.1 million 402.1 million 406.1 million
Total Current Assets 1.18 billion 1.18 billion N/A N/A 968.3 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets -418.9 million -418.9 million -538.2 million -538.2 million -605.9 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A 1.45 billion
Inventory 297.1 million 297.1 million N/A N/A 281.8 million
Accounts Payable 334.1 million 334.1 million N/A N/A 289.3 million

Convatec Group Plc (CNVVF) Chart:

Convatec Group Plc (CNVVF) News:

Below you will find a list of latest news for Convatec Group Plc (CNVVF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Convatec Group Plc (CNVVF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Convatec Group Plc (CNVVF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2017-04-19F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1694271/000101915517000112/0001019155-17-000112-index.htm
2017-01-12F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1694271/000119380517000033/0001193805-17-000033-index.htm
2017-03-08F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1694271/000119380517000422/0001193805-17-000422-index.htm
2017-07-25F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1694271/000119380517001315/0001193805-17-001315-index.htm
2017-09-29F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/1694271/000119380517002644/0001193805-17-002644-index.htm
2019-11-25F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1694271/000119380519001848/0001193805-19-001848-index.htm